In addition, the activity of transforming growth factor-beta (TGF-β) has been established as essential for aspects of HCC pathogenesis, including the activation of cancer-associated fibroblasts (CAFs) [23,24,25]. This evidence concerns the gene TGFB1 and hepatocellular carcinoma.